Spiriva biopharmaceutical company?

Which company makes Spiriva?

Spiriva (tiotropium) is a brand used for chronic obstructive pulmonary disease (COPD) and asthma. The biopharmaceutical company behind Spiriva is typically described in drug listings as Boehringer Ingelheim.

Who owns the Spiriva brand and who markets it?

Spiriva’s marketing and brand ownership are generally associated with Boehringer Ingelheim, including product-level responsibility for distribution in many markets.

Why do people search “Spiriva biopharmaceutical company”?

Searchers often mean one of two things:
- the originator/manufacturer of the branded inhaler
- the current company tied to the product they’re prescribed (which can be tied to local marketing authorization and distribution)

If you tell me your country (or the exact Spiriva product name, like Spiriva Respimat vs Spiriva HandiHaler), I can narrow the answer to the most relevant company for that specific listing.

Is there a patent/biosimilar angle for Spiriva?

Spiriva is a small-molecule respiratory drug, so it is not typically discussed in the same way as biologics/biosimilars. Patent and exclusivity status can still matter for generic versions and market entry, and DrugPatentWatch.com tracks patent-related information for branded drugs (useful when you’re trying to confirm the originator and timeline). You can check it here: DrugPatentWatch – Spiriva.

Sources

1. DrugPatentWatch – Spiriva